Albendazole Anthelmintic Drug Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DPH247 | Last Updated On: Feb 25 2021 | No. of Pages: 180 | Available Formats

> Global Albendazole Anthelmintic Drug Market Expected to reach a high CAGR By 2027: DataM Intelligence

Global Albendazole Anthelmintic Drug Market is segmented By Type (Tablet, Capsule, Others), By Application (Human, Veterinary), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

 

Market Overview

The Global Albendazole Anthelmintic Drug Market is expected to grow at a CAGR during the forecasting period (2020-2027).

Albendazole, also known as albendazole, is an anthelmintic drug. It inhibits the production or replication of new insect larvae (worms) in the body. It is used to combat inflammatory diseases from worms like pork wire and dog tapestry. For various purposes, albendazole can be used in humans and livestock. The capillary disease is caused by Capillary pelican (dogs and cats), and C is used in poultry. Cati Felis (cats). Capillary bladders infect, so they are sometimes referred to as bladder worms. With albendazole.

Source: DataM Intelligence Analysis (2019)

Market Dynamics

Due to growing neurocysticercosis cases, the demand for albendazole drugs will expand dramatically in the coming years (infection caused by the pork tapeworm in the muscles, brain, and eyes that may cause seizures, brain swelling, and vision problems). Besides, rising healthcare costs are expected to influence Fujimycin's Application. The alarmingly accurate occurrence of human parasitic worm infections has prompted companies in the market for anthelmintic medicines to expand their R&D potential for new drug candidates. For example, Bayer Animal Health, a multinational supplier of creative animal health solutions, announced in December 2019 that the organization is scaling up its research efforts to include potential anthelmintic drugs for the EU-sponsored partnership Project Aid (Helminth Removal Platform) for human care. Distinct parasitic worm types cause Soil-borne helminth infections. According to the WHO, nearly 1.5 billion people worldwide have suffered from soil-borne helminth infection as of March 2020. 24 percent of the global human population accounts for this figure. Ascaris lumbricoides (roundworms), trichuriasis trichiura (whipworms), necator americanus, and ancylostoma duodenale are major species that raise the disease burden (hookworms). According to WHO info, soil-transmitted helminth infection distribution in Sub-Saharan Africa, the Americas, China and countries in Asia was higher in March 2020.

Growing demand Albendazole Anthelmintic Drug in the treatment of Helmonthasis

Helmonthasis, also known as worm infection, is a human and other animal macroparasite disease that includes parasite worms in most of the body, known as helminths (helminths). A rise in the prevalence is expected to drive the market for anthelmintic medicine caused by roundworm, hookworm, whipworm and other worms. In exchange, the size of the global economy is projected to improve. For example, 12 cases, also known as rat lungworm, were registered in the U.S. in August 2018. In 2018, 2800 Angiostrongylus cantonensis cases were registered in thirty countries, according to the CDC. The National Deworming Day, for example, is a big effort by the Government of India's Ministry of Health and Family Welfare to make the nation worm-free. In India, 241 million children aged 1 to 14 years are at higher risk of parasitic intestinal worms, according to the WHO. The government is also expected to establish recommendations for awareness-raising and the eradication of helminth infection.

Side effects of Albendazole Anthelmintic Drug

Albendazole Anthelmintic Drug's side effects, such as headache, neck stiffness, increased sensitivity to light, confusion, and fever, may act as restraint of the market share. Further, Albendazole can increase your risk of bleeding or infection. 

COVID-19 Impact Analysis

With the continuing breakout of coronavirus COVID-19, the unprecedented need for medications to tackle the novel infection has been intensified. As a result, AI, Gero, is recognized as a global expert in AI-driven drug developments and validating promising anthelmintic drug therapy potentials for COVID-19. As a result, the treatment of coronavirus in patients with niclosamide has proven to be successful. It has been approved in the U.S., Italy, France, and few other countries where active COVID-19 patients are high. With the authorization of niclosamide, the effective use of AI-driven drug development approaches to build upon revenue-generating opportunities in industries on the anthelmintics market increases. Anthelmintic drug market firms are working to carry out clinical trials of existing therapeutic drugs that can be effective for treating coronavirus, which has further led to the demand for Albendazole Anthelmintic Drug.

Segmentation Analysis

Based on the Type, the Albendazole Anthelmintic Drug market has been classified into tablets, capsules and others.

Tablet Albendazole Anthelmintic Drug segment is projected to be the market's dominant segment during the forecast period.

The tablets segment accounts for the largest market share of the global Albendazole Anthelmintic Drug market and is projected to rise during the forecast period at its highest CAGR. The category of tablets and powders is growing primarily because of ease of use and relatively better absorption.

Albendazole Anthelmintic Drug is segmented based on Application, which includes Human and Veterinary.

The veterinary segment is expected to account for significant market share in the Albendazole Anthelmintic Drug market.

Different prevention steps for the management of parasites in animals are being introduced. Veterinarians rely on anthelmintic drugs to protect the animals' health as vaccines are not readily available, and better vaccines have to be developed. Companies take advantage of value capturing opportunities for improved animal health through increased available macrocyclic benzimidazoles and tetrahydro pyrimidines on the anthelmintic drugs market.

Source: DataM Intelligence Analysis (2019)

 Geographical Analysis

Based on geography, the study analyzes the Albendazole Anthelmintic Drug market globally, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North American Region is expected to dominate the global Albendazole Anthelmintic Drug market.

In North America, major research and development players will account for the significant share of global albendazole demand for medicines. The USA, for example. The Food and Drug Administration authorized the Cipla Abbreviated New Medication Request for Albendazole Tablets. Further, major players in the region are adopting the product launch o increase the product portfolio and gain competitive market share. For instance, Amneal Pharmaceuticals LLC and Impax Laboratory, Inc. joined the group in May of 2018 and founded a new Amneal Pharmaceuticals Inc. in May 2018. This acquisition would potentially improve Amneal's pharmaceutical industry as the fünfth largest generic firm in the United States. Moreover, the demand for albendazole drugs in Asia-Pacific is expected to develop rapidly in the timeframe predicted, as the prevalence of helminthic infection is growing and increasing.

 Competitive Landscape

The Albendazole Anthelmintic Drug market is moderately competitive, owing to major market players in the key regions such as the US, China, India and others. The key Albendazole Anthelmintic Drug players contributing to the growth of the global market include GlaxoSmithKline, Fredun Pharmaceuticals Ltd, Sequent Scientific, Huazhong Pharmaceutical, Zhongjia Pharmaceutical, Jiangsu Qihui, Salius Pharma, Lasa Supergenerics Limited, K.A. Malle Pharmaceuticals, Supharma Chem, among others. The major players are adopting new product launch and expansion strategies for global growth in the Albendazole Anthelmintic Drug market.   

GlaxoSmithKline:

Established in 2000 with Glaxo Wellcome and SmithKline Beecham's merger, GlaxoSmithKline plc (GSK) is a British multinational pharmaceuticals firm. The company is Adopting the strategy of merger and acquisition to expand its product portfolio and increase consumer outreach. For instance, In March 2018, GSK allied with Novartis to acquire the US$13 billion (£9.2 billion) of Novartis's 36.5% equity in its Joint Venture for Consumer Healthcare.

Why Purchase the Report?

  • Visualize the Albendazole Anthelmintic Drug market segmentation composition by Form, Application, and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the Albendazole Anthelmintic Drug market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of Albendazole Anthelmintic Drug market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players.

The global Albendazole Anthelmintic Drug market report would provide access to an approx. 51 market data table, 45 figures and 221 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Related Topic’s

Glucaric Acid Market

Propylene Glycols Market

 

Table of Contents

  1. Albendazole Anthelmintic Drug Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Albendazole Anthelmintic Drug Market – Market Definition and Overview

  3. Albendazole Anthelmintic Drug Market – Executive Summary

    1. Market Snippet by Type
    2. Market Snippet by Application
    3. Market Snippet by Region
  4. Albendazole Anthelmintic Drug Market – Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Growing demand Albendazole Anthelmintic Drug in the treatment of Helmonthasis
      2. Restraints:
        1. Side effects of Albendazole Anthelmintic Drug
      3. Impact Analysis
  5. Albendazole Anthelmintic Drug Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Value Chain Analysis
    4. PEST Analysis
    5. Pricing Analysis
    6. Regulatory Analysis
    7. Reimbursement Analysis
    8. Unmet Needs
    9. Patent Trends
  6. Albendazole Anthelmintic Drug Market – COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Albendazole Anthelmintic Drug Market – By Type

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    3. Market Attractiveness Index, By Type Segment
      1. Tablet
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Capsule
      3. Others
  8. Albendazole Anthelmintic Drug Market – By Application

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application  
    3. Market Attractiveness Index, By Application
      1. Human
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Veterinary
  9. Albendazole Anthelmintic Drug Market – By Region

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    3. Market Attractiveness Index, By Region
    4. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    5. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    6. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    7. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    8. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  10. Albendazole Anthelmintic Drug Market – Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Albendazole Anthelmintic Drug Market- Company Profiles

    1. GlaxoSmithKline
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Fredun Pharmaceuticals Ltd
    3. Sequent Scientific
    4. Huazhong Pharmaceutical
    5. Zhongjia Pharmaceutical
    6. Jiangsu Qihui
    7. Salius Pharma
    8. Lasa Supergenerics Limited
    9. K.A. Malle Pharmaceuticals
    10. Supharma Chem
  12. Albendazole Anthelmintic Drug Market – Premium Insights

  13. Albendazole Anthelmintic Drug Market – DataM Intelligence Analysis

    1. Appendix
    2. About Us and Services
    3. Contact Us (List Not Exhaustive)

 

List of Tables & Figures

List of Tables 

Table 1 Global Albendazole Anthelmintic Drug Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 2 Global Albendazole Anthelmintic Drug Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 3 Global Albendazole Anthelmintic Drug Market Value, By Region, 2019, 2023 & 2027 (US$ Million)

Table 4 North America Albendazole Anthelmintic Drug Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 5 North America Albendazole Anthelmintic Drug Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 6 North America Albendazole Anthelmintic Drug Market Value, By Country, 2018-2027 (US$ Million)

Table 7 South America Albendazole Anthelmintic Drug Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 8 South America Albendazole Anthelmintic Drug Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 9 South America Albendazole Anthelmintic Drug Market Value, By Country, 2018-2027 (US$ Million)

Table 10 Europe Albendazole Anthelmintic Drug Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 11 Europe Albendazole Anthelmintic Drug Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 12 Europe Albendazole Anthelmintic Drug Market Value, By Country, 2018-2027 (US$ Million)

Table 13 Asia Pacific Albendazole Anthelmintic Drug Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 14 Asia Pacific Albendazole Anthelmintic Drug Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 15 Asia Pacific Albendazole Anthelmintic Drug Market Value, By Country, 2019, 2023 & 2027 (US$ Million)

Table 16 The Middle East & Africa Albendazole Anthelmintic Drug Market Value, By Type, 2019, 2023 & 2027 (US$ Million)

Table 17 The Middle East & Africa Albendazole Anthelmintic Drug Market Value, By Application, 2019, 2023 & 2027 (US$ Million)

Table 18 The Middle East & Africa Albendazole Anthelmintic Drug Market Value, By Country, 2019, 2023 & 2027 (US$ Million)

Table 19 GlaxoSmithKline : Overview

Table 20 GlaxoSmithKline: Product Portfolio

Table 21 GlaxoSmithKline: Key Developments

Table 22  Fredun Pharmaceuticals Ltd: Overview

Table 23   Fredun Pharmaceuticals Ltd: Product Portfolio

Table 24   Fredun Pharmaceuticals Ltd: Key Developments

Table 25  Sequent Scientific: Overview

Table 26  Sequent Scientific: Product Portfolio

Table 27  Sequent Scientific: Key Developments

Table 28 Huazhong Pharmaceutical: Overview

Table 29 Huazhong Pharmaceutical: Product Portfolio

Table 30 Huazhong Pharmaceutical: Key Developments

Table 31 Jiangsu Qihui: Overview

Table 32 Jiangsu Qihui: Product Portfolio

Table 33 Jiangsu Qihui: Key Developments

Table 34 Salius Pharma: Overview

Table 35 Salius Pharma: Product Portfolio

Table 36 Salius Pharma: Key Developments

 

List of Figures

Figure 1 Global Albendazole Anthelmintic Drug Market Share, By Type, 2019 & 2027 (%)

Figure 2 Global Albendazole Anthelmintic Drug Market Share, By Application, 2019 & 2027 (%)

Figure 3 Global Albendazole Anthelmintic Drug Market Share, By Region, 2019 & 2027 (%)

Figure 4 Global Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 5 Global Albendazole Anthelmintic Drug Market Y-o-Y Growth, By Type, 2019-2027 (%)

Figure 6 Tablet: Global Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 7 Capsule: Global Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 8 Others: Global Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 9 Global Albendazole Anthelmintic Drug Market Y-o-Y Growth, By Application, 2019-2027 (%)

Figure 10 Human: Global Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 11 Veterinary: Global Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 12 North America Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 13 North America Albendazole Anthelmintic Drug Market Share, By Type, 2019 & 2027 (%)

Figure 14 North America Albendazole Anthelmintic Drug Market Share, By Application, 2019 & 2027 (%)

Figure 15 North America Albendazole Anthelmintic Drug Market Share, By Type, 2019 & 2027 (%)

Figure 16 North America Albendazole Anthelmintic Drug Market Share, By Country, 2019 & 2027 (%)

Figure 17 South America Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 18 South America Albendazole Anthelmintic Drug Market Share, By Type, 2019 & 2027 (%)

Figure 19 South America Albendazole Anthelmintic Drug Market Share, By Application, 2019 & 2027 (%)

Figure 20 South America Albendazole Anthelmintic Drug Market Share, By Country, 2019 & 2027 (%)

Figure 21 Europe Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 22 Europe Albendazole Anthelmintic Drug Market Share, By Type, 2019 & 2027 (%)

Figure 23 Europe Albendazole Anthelmintic Drug Market Share, By Application, 2019 & 2027 (%)

Figure 24 Europe Albendazole Anthelmintic Drug Market Share, By Country, 2019 & 2027 (%)

Figure 25 Asia-Pacific Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 26 Asia-Pacific Albendazole Anthelmintic Drug Market Share, By Type, 2019 & 2027 (%)

Figure 27 Asia-Pacific Albendazole Anthelmintic Drug Market Share, By Application, 2019 & 2027 (%)

Figure 28 Asia-Pacific Albendazole Anthelmintic Drug Market Share, By Country, 2019 & 2027 (%)

Figure 29 The Middle East & Africa Albendazole Anthelmintic Drug Market Value, 2018-2027 (US$ Million)

Figure 30 The Middle East & Africa Albendazole Anthelmintic Drug Market Share, By Type, 2019 & 2027 (%)

Figure 31 The Middle East & Africa Albendazole Anthelmintic Drug Market Share, By Application, 2019 & 2027 (%)

Figure 32 The Middle East & Africa Albendazole Anthelmintic Drug Market Share, By Country, 2019 & 2027 (%)

Figure 33 GlaxoSmithKline: Financials

Figure 34 Fredun Pharmaceuticals Ltd: Financials

Figure 35 Sequent Scientific: Financials

Figure 36 Huazhong Pharmaceutical: Financials

Figure 37 Zhongjia Pharmaceutical: Financials

Figure 38 Jiangsu Qihui: Financials

Figure 39 Salius Pharma: Financials

Figure 40 Lasa Supergenerics Limited: Financials

Figure 41 K.A. Malle Pharmaceuticals: Financials

Figure 42 Supharma Chem: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest